NOV Antikörper (AA 221-320)
Kurzübersicht für NOV Antikörper (AA 221-320) (ABIN761816)
Target
Alle NOV Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 221-320
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human IGFBP9/CCN3
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- NOV (Nephroblastoma Overexpressed (NOV))
-
Andere Bezeichnung
- Igfbp9
-
Hintergrund
-
Synonyms: CCN3, NOVh, IBP-9, IGFBP9, IGFBP-9, Protein NOV homolog, CCN family member 3, Insulin-like growth factor-binding protein 9, IGF-binding protein 9, Nephroblastoma-overexpressed gene protein homolog, NOV
Background: Immediate-early protein likely to play a role in cell growth regulation.
-
Gen-ID
- 4856
-
UniProt
- P48745
-
Pathways
- Smooth Muscle Cell Migration, Growth Factor Binding
Target
-